4 completed, 2 withdrawn. 6 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 6 | Completed 4, Withdrawn 2 |
Follow Refractory Solid Tumors: new trials by email Literature Review of Refractory Solid Tumors trials Research Report on Refractory Solid Tumors
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
Neoplasms (1)
Sorafenib (2) · pazopanib (2) · AVN 944 (1) · Sunitinib (1)
Samsung Medical Center (5) · Vertex Pharmaceuticals Incorporated (1)
South Korea (5) · United States (1)